4.8 Article

Dynorphin Controls the Gain of an Amygdalar Anxiety Circuit

Journal

CELL REPORTS
Volume 14, Issue 12, Pages 2774-2783

Publisher

CELL PRESS
DOI: 10.1016/j.celrep.2016.02.069

Keywords

-

Categories

Funding

  1. NARSAD Young Investigator Award [U01AA020911]
  2. BNORC Transgenic Core [P30 DK046200]
  3. BADERC Transgenic Core [P30 DK57521]
  4. McDonnell Center for Systems Neuroscience [R01DA033396]
  5. [R01AA019454]
  6. [R00AA017668]
  7. [R01DK096010]
  8. [R01DK089044]
  9. [R01DK071051]
  10. [R01DK075632]
  11. [R37DK053477]
  12. [F32 DK089710]

Ask authors/readers for more resources

Kappa opioid receptors (KORs) are involved in a variety of aversive behavioral states, including anxiety. To date, a circuit-based mechanism for KOR-driven anxiety has not been described. Here, we show that activation of KORs inhibits glutamate release from basolateral amygdala (BLA) inputs to the bed nucleus of the stria terminalis (BNST) and occludes the anxiolytic phenotype seen with optogenetic activation of BLA-BNST projections. In addition, deletion of KORs from amygdala neurons results in an anxiolytic phenotype. Furthermore, we identify a frequency-dependent, optically evoked local dynorphin-induced heterosynaptic plasticity of glutamate inputs in the BNST. We also find that there is cell type specificity to the KOR modulation of the BLA-BNST input with greater KOR-mediated inhibition of BLA dynorphin-expressing neurons. Collectively, these results provide support for a model in which local dynorphin release can inhibit an anxiolytic pathway, providing a discrete therapeutic target for the treatment of anxiety disorders.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.8
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available